Our Commitment to Sustainability
At Gilead, sustainability is embedded into our culture and throughout our operations and supply chain. We're committed to discovering, developing and delivering medicines in a way that positively contributes to environmentally sustainable outcomes. We recognize the connection between environmental sustainability and human health as we work to build a healthier, more equitable world.
We set ambitious environmental targets and have robust programs in place across the four focus areas where we can have the most impact: carbon, water, waste and product.
Sustainability Targets for a Healthier World
Read the 2025 Responsible Business & Impact ReportSome of the content on this page is not intended for users outside the U.S.
Carbon
- Reduce Scope 1, 2 GHG emissions 46%, Scope 3 emissions 15% & achieve carbon net-zero operational emissions by 2030
- Transition all fleet vehicles to electric or low emissions by 2030
- Utilize 100% renewable electricity in operations by 2025
Waste
- Reduce total waste generation by 20% by 2030
- Achieve zero waste to landfill status at all owned facilities by 2030
- Eliminate single-use plastics at our offices by 2025
Water
- Reduce potable water use at owned facilities by 30% compared to 2019 and achieve water neutrality in the water-stressed regions we operate in by 2030
Product
- 100% product packaging widely recyclable or reusable, including elimination of all unnecessary plastics
- Use 30% post-consumer recycled content in all plastic packaging and 70% recycled content paper by 2025
2024 Progress Against Targets
Progress toward SBTi Scope 1 & 2 emissions target, while real estate footprint expanded 18% from 2019
Operational electricity demand comes from renewable sources
Global fleet vehicle are plug-in hybrids or electric vehicles
Packaging is widely recyclable
*where quality, availability, and safety permit; target excludes primary packaging
Owned facilities that have achieved Zero Waste to Landfill status
Targeted single-use plastics eliminated
ACHIEVEMENTS
Kilowatt-hours per year in energy consumption avoided through conservation measures 2021-2025
Kiloliters of water saved through conservation measures 2021-2025
Reduction in energy use in 2025 while floor area increased by 17% since 2019
MT GHG emissions avoided using sustainable aviation fuel in 2025
Gilead sites with 100+ employees provide employee access to EV charging
Supplier spend is with suppliers that have set, or have formally committed to setting SBTi-aligned targets
Sustainable Research and Development
The ability to incorporate sustainable business practices while executing complex scientific processes is core to how Gilead operates. This sustainability focus is embedded across all of Gilead’s laboratory and manufacturing operations, from integrating the 12 principles of green chemistry throughout the small molecule development process to our work on cancer treatments.
As we engage our scientists to build on our sustainability culture, we align with the principles outlined by the nonprofit group My Green Lab® (MGL), a globally recognized certification program for scientific laboratory sustainability. Hundreds of researchers have participated and we've achieved MGL certifications across multiple facilities.
Sustainability Focus Areas
Gilead is committed to the socially and environmentally responsible production of medicines that improve and save lives worldwide.
ESG
We are working toward our target goals and making a positive impact on the environment with our performance objectives.